New Rhode Island lab to develop vaccines

Researchers at the newly formed Institute for Immunology and Informatics at the University of Rhode Island will focus on developing vaccines for diseases that are rampant in poor countries, including malaria, dengue fever, AIDS and tuberculosis, using a "genome-to-vaccine" approach. The institute will have access to the bioinformatics tools of biotech firm EpiVax in exchange for partial rights to potential disease-prevention discoveries.

View Full Article in:

Providence Journal (R.I.) (free registration), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC